Angel Asensio1, Stefano Di Bella2, Andrea Lo Vecchio3, Santiago Grau4, Warren M Hart5, Beatriz Isidoro6, Ricardo Scotto3, Nicola Petrosillo2, Maureen Watt7, Jameel Nazir7. 1. Hospital Universitario Puerta de Hierro, C/ Manuel de Falla 1, Majadahonda 28222, Madrid, Spain; University Francisco de Vitoria, Madrid, Spain. Electronic address: aasensiov@salud.madrid.org. 2. National Institute for Infectious Diseases "L. Spallanzani", Rome, Italy. 3. Department of Translational Medical Science, University of Naples "Federico II", Naples, Italy. 4. Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain. 5. EcoStat Consulting UK Ltd, London, UK. 6. HM Hospitales, Madrid, Spain. 7. Astellas Pharma EMEA, Chertsey, UK.
Abstract
OBJECTIVE: To assess the impact of Clostridium difficile infection (CDI) on hospital resources and costs in Spain and Italy. METHODS: CDI data were collected from institutions in Spain and Italy. Each patient was matched with two randomly selected uninfected controls in the same institution. Patient outcomes were assessed for the first and second episodes of CDI and for patients aged ≤65 and >65 years. The impact of CDI on hospital length of stay (LOS) was used to calculate CDI-attributable costs. A multivariate analysis using duration of stay as the continuous outcome variable assessed the independent effect of CDI on hospital costs and LOS. RESULTS: LOS attributable to CDI ranged from 7.6-19.0 days in adults and was 5.0 days in children; the increases were greater in adults in Italy than in Spain. Attributable costs per adult patient ranged from €4396 in Madrid to €14 023 in Rome, with the majority of the cost being due to hospitalization. For children, the total attributable cost was €3545/patient. CONCLUSIONS: These data show that the burden of CDI is considerable in Spain and Italy. Treatments that can reduce LOS, disease severity, and recurrence rates, as well as effective infection control measures to prevent transmission, have the potential to reduce the burden of CDI.
OBJECTIVE: To assess the impact of Clostridium difficileinfection (CDI) on hospital resources and costs in Spain and Italy. METHODS: CDI data were collected from institutions in Spain and Italy. Each patient was matched with two randomly selected uninfected controls in the same institution. Patient outcomes were assessed for the first and second episodes of CDI and for patients aged ≤65 and >65 years. The impact of CDI on hospital length of stay (LOS) was used to calculate CDI-attributable costs. A multivariate analysis using duration of stay as the continuous outcome variable assessed the independent effect of CDI on hospital costs and LOS. RESULTS: LOS attributable to CDI ranged from 7.6-19.0 days in adults and was 5.0 days in children; the increases were greater in adults in Italy than in Spain. Attributable costs per adult patient ranged from €4396 in Madrid to €14 023 in Rome, with the majority of the cost being due to hospitalization. For children, the total attributable cost was €3545/patient. CONCLUSIONS: These data show that the burden of CDI is considerable in Spain and Italy. Treatments that can reduce LOS, disease severity, and recurrence rates, as well as effective infection control measures to prevent transmission, have the potential to reduce the burden of CDI.
Authors: M D Esteban-Vasallo; S Naval Pellicer; M F Domínguez-Berjón; M Cantero Caballero; Á Asensio; G Saravia; J Astray-Mochales Journal: Eur J Clin Microbiol Infect Dis Date: 2016-04-07 Impact factor: 3.267
Authors: A Lo Vecchio; L Lancella; C Tagliabue; C De Giacomo; S Garazzino; M Mainetti; L Cursi; E Borali; M V De Vita; E Boccuzzi; L Castellazzi; S Esposito; A Guarino Journal: Eur J Clin Microbiol Infect Dis Date: 2016-09-30 Impact factor: 3.267
Authors: Vimalanand S Prabhu; Oliver A Cornely; Yoav Golan; Erik R Dubberke; Sebastian M Heimann; Mary E Hanson; Jane Liao; Alison Pedley; Mary Beth Dorr; Stephen Marcella Journal: Clin Infect Dis Date: 2017-10-01 Impact factor: 9.079
Authors: Emilio Bouza; Oliver A Cornely; Antonio Ramos-Martinez; Robert Plesniak; Misoo C Ellison; Mary E Hanson; Mary Beth Dorr Journal: Eur J Clin Microbiol Infect Dis Date: 2020-06-06 Impact factor: 3.267
Authors: E Bouza; J Cobo; M J Rodríguez-Hernández; M Salavert; J P Horcajada; J A Iribarren; E Obi; V Lozano; S Maratia; M Cuesta; E Uría; E Limón Journal: Rev Esp Quimioter Date: 2021-02-23 Impact factor: 1.553